Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients
NCT01418846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2015-01-13
Summary
The purpose of this study is to investigate the intra-saliva penetration of voriconazole in different subpopulations. The goal is to develop, optimize and validate an easy, non-invasive and painless procedure for Therapeutic Drud Monitoring of voriconazole that can be used in children, ambulatory patients and in patients in whom blood drawing is difficult.
Conditions
- Pneumology
- Hematology
- Internal Medicine
- Pediatrics
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Kim Vanstraelen, R.Ph. · Catholic University of Leuven, Faculty of Pharmacy, division Hospital Pharmacy
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-11-30
Countries
- Belgium
Study Locations
More Related Trials
-
A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects
NCT00940017 ·Status: COMPLETED ·Phase: PHASE4
-
Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection
NCT01137292 ·Status: COMPLETED
-
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
NCT01416025 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Inflammation on Voriconazole Concentration
NCT02074462 ·Status: COMPLETED
-
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection
NCT00739934 ·Status: COMPLETED ·Phase: PHASE2
-
Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration
NCT02396225 ·Status: TERMINATED ·Phase: NA
-
Antifungal Use in Oncohematological Neutropenic Patients
NCT00386802 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001810 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Drug Monitoring of Voriconazole
NCT00890708 ·Status: COMPLETED ·Phase: NA
-
Voriconazole Blood Levels and Toxicity
NCT00359541 ·Status: COMPLETED
-
A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents
NCT00556998 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Two Different Formulation of Voriconazole
NCT02912156 ·Status: COMPLETED ·Phase: PHASE4
-
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
NCT00904995 ·Status: COMPLETED ·Phase: PHASE3
-
Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
NCT01151085 ·Status: COMPLETED
-
Voriconazole to Prevent Systemic Fungal Infections in Children
NCT00005912 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy
NCT00136968 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacologic Optimization of Voriconazole
NCT00893555 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections
NCT00647907 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects
NCT05330000 ·Status: COMPLETED ·Phase: PHASE1
-
Vfend Special Investigation For Prophylaxis
NCT02674685 ·Status: COMPLETED
-
Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)
NCT01660334 ·Status: COMPLETED
-
Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism
NCT00175994 ·Status: COMPLETED
-
Assessment of Target Site Pharmacokinetics of Voriconazole in Healthy Volunteers During Sequence Therapy
NCT01539330 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001757 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection
NCT01383993 ·Status: COMPLETED ·Phase: PHASE2